Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 415,800 | 406,300 | 485,100 | 522,000 | 383,300 |
| Receivables | 212,500 | 482,600 | 517,700 | 503,500 | 422,000 |
| Inventories | 186,500 | 421,100 | 462,700 | 406,400 | 350,000 |
| Income taxes - deferred | 34,900 | 33,000 | 35,600 | 44,500 | 40,600 |
| Other current assets | 438,100 | 31,000 | 19,500 | 27,000 | 115,500 |
| TOTAL | $1,287,800 | $1,374,000 | $1,520,600 | $1,503,400 | $1,311,400 |
| Non-Current Assets | |||||
| PPE Net | 724,700 | 1,105,200 | 1,132,800 | 1,123,900 | 1,126,200 |
| Investments And Advances | 0 | 20,200 | 21,500 | 21,500 | 19,700 |
| Intangibles | 326,700 | 1,003,300 | 1,053,800 | 1,050,400 | 1,032,700 |
| Other Non-Current Assets | 1,197,500 | 128,000 | 128,300 | 127,300 | 183,900 |
| TOTAL | $2,248,900 | $2,256,700 | $2,336,400 | $2,323,100 | $2,362,500 |
| Total Assets | $3,536,700 | $3,630,700 | $3,857,000 | $3,826,500 | $3,673,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,500 | 4,300 | 3,700 | 6,300 | 6,100 |
| Accounts payable and accrued liabilities | 118,900 | 303,800 | 381,800 | 380,500 | 263,600 |
| Accrued Expenses | 126,100 | 222,000 | 217,600 | 191,800 | 223,200 |
| Other current liabilities | 252,000 | 0 | 0 | N/A | 63,900 |
| TOTAL | $521,900 | $556,400 | $631,600 | $637,100 | $579,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 635,900 | 636,000 | 636,100 | 639,900 | 641,500 |
| Other Non-Current Liabilities | 643,400 | 599,000 | 629,300 | 630,600 | 643,900 |
| TOTAL | $1,321,500 | $1,314,700 | $1,338,500 | $1,340,300 | $1,357,400 |
| Total Liabilities | $1,843,400 | $1,871,100 | $1,970,100 | $1,977,400 | $1,937,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 91,637 | 99,172 | 99,170 | 98,412 | 98,902 |
| Common Shares | 500 | 500 | 500 | 500 | 500 |
| Retained earnings | 1,476,400 | 1,440,700 | 1,398,900 | 1,370,000 | 1,293,000 |
| Other shareholders' equity | -59,800 | -19,100 | 69,400 | 43,600 | -8,100 |
| TOTAL | $1,693,300 | $1,759,600 | $1,886,900 | $1,849,100 | $1,736,900 |
| Total Liabilities And Equity | $3,536,700 | $3,630,700 | $3,857,000 | $3,826,500 | $3,673,900 |